1-3 of 3
Richard Benya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum

Daniel L. Gillen, Frank L. Meyskens, Timothy R. Morgan, Jason A. Zell, Robert Carroll, Richard Benya, Wen-Pin Chen, Allen Mo, Chris Tucker, Asmita Bhattacharya, Zhiliang Huang, Myra Arcilla, Vanessa Wong, Jinah Chung, Rachel Gonzalez, Luz Maria Rodriguez, Eva Szabo, Daniel W. Rosenberg, Steven M. Lipkin
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2015) 8 (3): 222–230.
https://doi.org/10.1158/1940-6207.CAPR-14-0148
Published: 05 March 2015
View article titled, A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum
Open the PDF for A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum in another window
Includes: Supplementary data
Journal Articles

Abstract CN07-01: A phase IIa randomized, double-blind trial of erlotinib in inhibiting EGF receptor signaling in aberrant crypt foci of the colon

Steven Lipkin, Asmita Bhattacharya, Timothy Morgan, Jason Zell, Daniel Gillen, Vanessa Wong, Jinah Chung, Wen Pin Chen, Rachel Gonzalez, Frank Meyskens, Luz Rodriguez, Eva Szabo, Robert Carroll, Richard Benya
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (11_Supplement): CN07-01.
https://doi.org/10.1158/1940-6215.PREV-13-CN07-01
Published: 28 August 2014
View article titled, Abstract CN07-01: A phase IIa randomized, double-blind trial of erlotinib in inhibiting EGF receptor signaling in aberrant crypt foci of the colon
Journal Articles

Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention

Paul J. Limburg, Michelle R. Mahoney, Katie L. Allen Ziegler, Stephen J. Sontag, Robert E. Schoen, Richard Benya, Michael J. Lawson, David S. Weinberg, Elena Stoffel, Michael Chiorean, Russell Heigh, Joel Levine, Gary Della'Zanna, Luz Rodriguez, Ellen Richmond, Christopher Gostout, Sumithra J. Mandrekar, Thomas C. Smyrk
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2011) 4 (2): 259–269.
https://doi.org/10.1158/1940-6207.CAPR-10-0215
Published: 02 February 2011
View article titled, Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention
Open the PDF for Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention in another window